MétaCan
Menu
Retour à la cohorte
Enregistrement W2056095894 · doi:10.4088/pcc.v09n0311f

Risperidone-Induced Neuroleptic Malignant Syndrome in Neurodegenerative Disease

2007· letter· en· W2056095894 sur OpenAlexaff
Daniel M. Johnson, Aby Philip, Dennis Joseph, Roy Varghese

Notice bibliographique

RevueThe Primary Care Companion to The Journal of Clinical Psychiatry · 2007
Typeletter
Langueen
DomaineMedicine
ThématiqueElectroconvulsive Therapy Studies
Établissements canadiensSt Mary's Hospital Centre
Organismes subventionnairesnon disponible
Mots-clésNeuroleptic malignant syndromeRisperidoneMedicineDiseasePsychiatrySchizophrenia (object-oriented programming)Internal medicine

Résumé

récupéré en direct d'OpenAlex

Quetiapine-Induced HypersalivationSir: Quetiapine fumarate is a dibenzothiazepinederivative antipsychotic with combined antagonism at dopamine (D 1 , D 2 ) and serotonin type 1 and type 2 (5-HT 1A , 5-HT 2A , 5-HT 2C ) receptors.Additionally, quetiapine antagonizes α 1 -and α 2 -adrenergic and histamine H 1 receptors.Protean binding at the above receptors explains the common side effects, which include hypersomnolence, hypotension, headache, weight gain, and gastrointestinal disturbance.However, to our knowledge, there have been no case reports of quetiapine-induced hypersalivation.We report the case of a patient with schizoaffective disorder taking low-dose quetiapine who developed hypersalivation, which remitted after discontinuation of the drug.We suggest that quetiapine antagonism at the α 2 receptor contributes to the phenomenon of hypersalivation.Case report.Ms. A, a 36-year-old woman of Korean descent with a 16-year history of schizoaffective disorder, was admitted to the adult psychiatric medical care unit with a relapse of mania with psychosis.The patient's symptoms included elated mood, grandiose delusions of being a Power Ranger, disorganized behavior, and decreased need for sleep.The patient had been previously stabilized on clozapine with the only noted side effect being increased sedation.During this hospitalization, the patient refused administration of clozapine and instead was started on risperidone.Within a few days of commencement, the patient developed extrapyramidal symptoms with rigidity, dystonia, and slurring of speech, which prompted discontinuation of the risperidone.After a drug-free period of 3 days, the patient was started on quetiapine 25 mg b.i.d., and within a day, she developed increased salivation.When the dosage was increased to 50 mg b.i.d., the salivation worsened; the patient was drooling most of the day, and all of her clothing was wet.Benztropine (1 mg p.o. b.i.d.) and atropine eye drops (0.1%) sublingually did not reduce the hypersalivation.The quetiapine was stopped, and 1 day later, the hypersalivation resolved.Based on the temporal relationship between the administration and discontinuation of quetiapine and the onset and cessation of the patient's hypersalivation, it is possible that the hypersalivation was induced by the quetiapine.Hypersalivation is a common and distressing side effect seen with many psychotropic medications.However, no previous reports have associated increased salivation with the use of quetiapine.We attempt to explain the mechanism behind this event using the drug's known receptor affinities and the resultant binding effects observed in a closely related antipsychotic agent.Among the antipsychotics, clozapine is well recognized for inducing increased, voluminous salivation early in the course of treatment in up to 54% of patients. 1Clozapine is structurally similar to quetiapine and possesses a comparably broad receptor profile, which includes antagonistic activity at dopamine (D 1 , D 2 , D 3 , D 4 ) receptors, adrenergic blockade activity at the α 1 and α 2 receptors, and antagonism at serotonin 5-HT 2 receptors and histamine H 1 receptors.However, unlike quetiapine, clozapine possesses both agonistic and antagonistic properties at muscarinic receptors.Specifically, clozapine has antagonist activity at M 1 , M 2 , M 3 , and M 5 receptors, but exhibits agonist effects on the M 4 receptor.One proposed mechanism for clozapine-induced hypersalivation focuses on its antagonism of α 2 -adrenergic receptors. 2Through blockade of sympathetic stimulation, parasympathetic stimulation is left unopposed to cause high salivary flow rates.Direct parasympathetic stimulation through its agonist effects at the M 4 receptor has also been suggested to explain clozapine-induced hypersalivation. 3 Quetiapine and clozapine both share blocking affinity at α 2 -adrenergic receptors, whereas only clozapine has agonist properties at the M 4 receptor.We thus propose that α 2 -adrenergic blockade is the mechanism for quetiapineinduced hypersalivation.Further study is needed to draw definite conclusions regarding this proposed relationship.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,003
score de la tête « metaresearch » (Gemma)0,000
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesMéta-épidémiologie (sens strict), Intégrité de la recherche
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: aucune
GenreSignal candidat: Commentaire · Signal consensuel: Commentaire
Score de désaccord entre enseignants0,774
Score d'incertitude au seuil1,000

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0030,000
Méta-épidémiologie (sens strict)0,0010,000
Méta-épidémiologie (sens large)0,0020,001
Bibliométrie0,0000,001
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0010,000
Intégrité de la recherche0,0000,009
Charge utile insuffisante (le modèle a refusé de juger)0,0000,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,051
Tête enseignante GPT0,365
Écart entre enseignants0,313 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.

Devis d'étudeSans objet
Domainenon disponible
GenreCommentaire

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations5
Publié2007
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueThe Primary Care Companion to The Journal of Clinical PsychiatryMême sujetElectroconvulsive Therapy StudiesTravaux en français237 207